Aptose Biosciences Performance
| APTODelisted Stock | USD 2.01 0.91 82.73% |
The firm shows a Beta (market volatility) of 0.21, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Aptose Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Aptose Biosciences is expected to be smaller as well. Aptose Biosciences right now shows a risk of 0.0%. Please confirm Aptose Biosciences treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Aptose Biosciences will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Aptose Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Aptose Biosciences is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Aptose |
Aptose Biosciences Relative Risk vs. Return Landscape
If you would invest 201.00 in Aptose Biosciences on October 24, 2025 and sell it today you would earn a total of 0.00 from holding Aptose Biosciences or generate 0.0% return on investment over 90 days. Aptose Biosciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Aptose, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aptose Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aptose Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aptose Biosciences, and traders can use it to determine the average amount a Aptose Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| APTO |
Based on monthly moving average Aptose Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptose Biosciences by adding Aptose Biosciences to a well-diversified portfolio.
Aptose Biosciences Fundamentals Growth
Aptose Stock prices reflect investors' perceptions of the future prospects and financial health of Aptose Biosciences, and Aptose Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aptose Stock performance.
| Return On Equity | -6.94 | |||
| Return On Asset | -1.42 | |||
| Current Valuation | 9.69 M | |||
| Shares Outstanding | 2.55 M | |||
| Price To Earning | (1.80) X | |||
| Price To Book | 67.84 X | |||
| EBITDA | (36.15 M) | |||
| Cash And Equivalents | 62.41 M | |||
| Cash Per Share | 0.68 X | |||
| Total Debt | 621 K | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | (14.04) X | |||
| Cash Flow From Operations | (35.98 M) | |||
| Earnings Per Share | (36.38) X | |||
| Total Asset | 10.13 M | |||
| Retained Earnings | (540.97 M) | |||
| Current Asset | 14.98 M | |||
| Current Liabilities | 1.7 M | |||
About Aptose Biosciences Performance
By examining Aptose Biosciences' fundamental ratios, stakeholders can obtain critical insights into Aptose Biosciences' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Aptose Biosciences is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada. Aptose Bioscns operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.Things to note about Aptose Biosciences performance evaluation
Checking the ongoing alerts about Aptose Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aptose Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aptose Biosciences is not yet fully synchronised with the market data | |
| Aptose Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (25.43 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Aptose Biosciences currently holds about 62.41 M in cash with (35.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68. | |
| Roughly 25.0% of the company shares are held by company insiders |
- Analyzing Aptose Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aptose Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Aptose Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aptose Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aptose Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aptose Biosciences' stock. These opinions can provide insight into Aptose Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Aptose Stock
If you are still planning to invest in Aptose Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptose Biosciences' history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Transaction History View history of all your transactions and understand their impact on performance |